Product Information
ALPRAZOLAM XR 0.5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1533 per EA under NDC 59762005701. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 17, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762005701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALPRAZOLAMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021434FDA Approved
1/17/2003
TE Code
AB
On Market Since
1/17/2003
Pharmacological Classes
Price Statistics
The NADAC for ALPRAZOLAM XR 0.5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 49.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1533 per EA |
|---|---|
| All-time high | $0.3715 (Feb 12, 2014) |
| All-time low | $0.1195 (Jun 17, 2020) |
| 52-week high | $0.1713 |
| 52-week low | $0.1483 |
| Median price | $0.1892 |
| Average price | $0.2206 |
| Largest weekly change | +38.7% (Jul 22, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
alprazolam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALPRAZOLAM XR 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALPRAZOLAM XR 0.5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1533 per EA (NDC 59762005701), effective Sep 30, 2026.
How has the price of ALPRAZOLAM XR 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALPRAZOLAM XR 0.5 MG TABLET has declined 49.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPRAZOLAM XR 0.5 MG TABLET?
Since Nov 28, 2013, the NADAC for ALPRAZOLAM XR 0.5 MG TABLET has ranged from a low of $0.1195 (Jun 17, 2020) to a high of $0.3715 (Feb 12, 2014), with a median of $0.1892 per EA.
Are there cheaper alternatives to ALPRAZOLAM XR 0.5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALPRAZOLAM 0.5 MG TABLET, is $0.0225 per EA — about 85% below ALPRAZOLAM XR 0.5 MG TABLET.
Who manufactures ALPRAZOLAM XR 0.5 MG TABLET?
ALPRAZOLAM XR 0.5 MG TABLET (NDC 59762005701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.